Welcome
Apply Online Now
Prospective Students
Current Students
Curriculum
Research
Faculty
Campus
Resources
Seminar Series
PREP
Contact Information
Site Map
Search



peir.net

peir.net


Kevin Nash Mail Email this article  
 Print Printer friendly page  


Previous | Molecular & Cellular Pathology Graduate Student Profiles | Next

My research experiences after college and during my masters degree training piqued my interest in translational cancer research. As a result, I entered the Medical Scientist Training Program at UAB in order to bridge the gap between basic science and medicine. During my PhD. training I gained a strong interest in the area of melanoma metastasis research.

Currently, my future plans are to pursue a career in Dermatology and split my clinical time with translational melanoma metastasis research. My goal is to identify therapeutic targets for anti-metastatic therapies that could eventually be implemented in my clinical practice.





   Hometown:

Lanesboro, MA



Undergraduate/Masters Institution:

University of Massachusetts
at Amherst

Penn State College of Medicine



General Research Interests:

Cancer metastasis



 

Metastasis is the major cause of mortality
in cancer patients. Our laboratory is investigating the genetic and molecular mechanisms that lead to the metastatic phenotype in cancer cells.

 


In particular, we are discovering and characterizing metastasis suppressor genes. Although there are 20+ metastasis suppressors that have been identified to date, a mechanistic understanding of how these genes mediate their anti-metastatic effects remain unclear. Understanding how these genes prevent cancer cells from becoming metastatic will be essential for potential therapeutic intervention.

My thesis work focuses on characterizing the human metastasis suppressor gene KISS1. I have shown that KISS1 is a secretion dependent multiple organ metastasis suppressor that keeps disseminated metastatic cells dormant. This work has provided significant insight into both KISS1's mechanism and site of action opening the possibility of exogenous KISS1 administration for anti-metastatic therapy in the future.


Previous | Molecular & Cellular Pathology Graduate Student Profiles | Next




© Copyright by the University of Alabama at Birmingham

Site Last Updated: Jun 19th, 2006 - 09:48:29

Top of Page